LDL receptor-related protein (LRP): a multiligand receptor

Fibrinolysis and Proteolysis

Volumn 8, Issue SUPPL. 1, 1994, Pages 204-215

  Strickland, D K ^b   Kounnas, M Z ^a   Williams, S E ^b   Argraves, W S ^b  

^a HOLLAND LABORATORY   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN RECEPTOR;

CONFERENCE PAPER; HUMAN; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BINDING;

EID: 0027937023     PISSN: 02689499     EISSN: None     Source Type: Journal    
DOI: 10.1016/0268-9499(94)90718-8     Document Type: Article

References (104)

1. 2-macroglobulin
2. Purification of the rat hepatic a2macroglobulin receptor as an approximately 440 kDa single chain polypeptide
3. 2-macroglobulin receptor and low density lipoprotein receptorrelated protein suggests that this molecule is a multifunctional receptor
4. Evidence that the newly cloned LRP is the a2-macroglobulin receptor
5. Surface location and high affinity for calcium of a 500 kDa liver membrane protein closely related to the LDL receptor suggests a physiological role as lipoprotein receptor
6. LDL receptor-related protein internalizes and degrades uPA-PAI-1 complexes and is essential for embryo implantation
7. 2-macroglobulin receptor
8. 2-macroglobulin-proteinase complex is achieved by binding to adjacent receptors
9. 2- macroglobulin receptor
10. 2-macroglobulin receptor/low density lipoprotein receptorrelated protein. Multiple regulatory sites for 39-kDa receptor-associated protein
11. The human LDL receptor: A cysteine-rich protein with multiple Alu sequences in its mRNA
12. NPXY, a sequence often found in cytoplasmic tails, is required for coated pit-mediated internalization of the low density lipoprotein receptor
13. Acid-dependent ligand dissociation and recycling of LDL receptor mediated by growth factor homology region
14. Different combinations of cysteine-rich repeats mediate binding of LDL receptor to different proteins
15. Rabbit very low density lipoprotein receptor: a low density lipoprotein receptor-like 0protein with distinct ligand specificity
16. Structure, chromosome location, and expression of the human very low density lipoprotein receptor gene
17. The LDL receptor gene: A mosaic of exons shared with different proteins
18. The somatic cell-specific low density lipoprotein receptor-related protein of the chicken. Close kinship to mammalian low density lipoprotein receptor gene family members
19. 2-macroglobulin receptor cDNA
20. A gene for a low density lipoprotein receptor-related protein in the nematode Caenorhabditis elegans
21. The pathogenic antigen of Heymann nephritis is a membrane glycoprotein of the renal proximal tubule brush border
22. Autoimmune target in Heymann nephritis is a glycoprotein with homology to the LDL receptor
23. 2-macroglobulin receptor and glycoprotein 330
24. Chromosomal localization of human genes for the LDL receptor family member glycoprotein 330 and its associated protein RAP
25. A receptor-mediated pathway for cholesterol homeostasis
26. Low density lipoprotein receptor-related protein mediates uptake of cholesterol esters derived from apolipoprotein E-enriched lipoproteins
27. 2-macroglobulin receptor mediates cellular uptake of pro-urokinase
28. 2-macroglobulin receptor
29. 2-macroglobulin receptor is an hepatic receptor for tissue-type plasminogen activator
30. 2-macroglobuin receptor mediates cellular degradation of urokinase receptor-bound complexes
31. 2-macroglobulin receptor in vitro. A process facilitated by cell-surface proteoglycans
32. Glycoprotein 330, a member of the LDL receptor family, binds lipoprotein lipase in vitro
33. LDL receptor released protein and gp330 bind similar ligands, including plasminogen activator-inhibitor complexes and lactoferrin, an inhibitor of chylomicron remnant clearance
34. 2-macroglobulin receptor, and the receptor-associated protein (RAP)
35. Distribution of the a2macroglobulin receptor/low density lipoprotein receptorrelated protein in human tissues
36. Immunological localization of glycoprotein 330, low density lipoprotein receptor related protein and 39 kDa receptor associated protein in embryonic mouse tissues.
37. 2-macroglubin: High-affinity binding of complexes to the same receptor on fibroblasts and characterization of monoclonal antibodies
38. Effect of the 39 kDa receptor-associated protein on the hepatic uptake and endocytosis of chylomicron remnants and LDL in rats
39. Inhibition of hepatic chylomicron remnant uptake by gene transfer of a receptor antagonist.
40. 2-macroglobulin receptor/low density lipoprotein receptor-related protein binds and internalizes Pseudomonas exotoxin A
41. Structure of exotoxin A of Pseudomonas aeruginosa at 3.0-Angstrom resolution
42. Recombinant toxins for cancer treatment
43. Processing of pseudomonas exotoxin by a cellular protease results in the generation of a 37,000-Da toxin fragment that is translocated to the cytosol
44. Mutational analysis of domain I of PE
45. Members of the low density lipoprotein receptor family mediate cell entry of a minor-group common cold virus
46. Familiar hypercholesterolemia
47. Cholesterol ester synthesis in macrophages: Stimulation by β-VLDL from cholesterol-fed animals of several species
48. Opposing effects of apolipoproteins E and C on lipoprotein binding to LDL receptor related protein
49. LRP target or decoy
50. Chylomicron-chylomicron remnant clearance by liver and bone marrow in rabbits. Factors that modify tissue specific uptake
51. Lipoprotein lipase enhances the binding of chylomicrons to low density lipoprotein receptor-related protein
52. 2-macroglobulin receptor binds and mediates catabolism of bovine milk lipoprotein lipase
53. Strategies for the improvement of thrombolytic agents
54. Thrombolytic therapy in acute myocardial infarction
55. Binding of tissue-type plasminogen activator by the mannose receptor
56. Isolation and characterization of three different carbohydrate chains from melanoma tissue plasminogen activator
57. Tyrosine 67 in the epidermal growth factor-like domain of tissue-type plasminogen activator is important for clearance by a specific hepatic receptor
58. Deletion of a tripeptide sequence from the growth-factor domain of tissue-type plasminogen activator prolongs in vivo circulation
59. 39-kDa protein inhibits tissue-type plasminogen activator clearance in vivo
60. In vivo and in vitro interactions of high and low molecular weight single-chain urokinase-type plasminogen activator with rat liver cells
61. Studies on metabolism of urokinase and mechanism of thrombolysis by urokinase
62. Biological and thrombolytic properties of proenzyme and active forms of human urokinaseII turnover of natural and recombinant urokinase in rabbits and squirrel monkeys
63. Biochemical properties of recombinant single chain urokinase-type plasminogen activator mutants with deletion of Asn2 through Phe 157 and/or substitution of Cys279 with Ala
64. A cellular binding site for the Mr 55 000 form of the human plasminogen activator, urokinase
65. Cellular receptor for urokinase plasminogen activator. Carboxyl-terminal processing and membrane anchoring by glycosyl-phosphatidylinositol
66. The urokinase receptor and regulation of cell surface plasminogen activation
67. The urokinase receptor and the regulation of cell surface plasminogen activation
68. Urokinase and urokinase receptor: A paracrine/ autocrine system regulating cell migration and invasiveness
69. Receptor-mediated internalization and degradation of urokinase is caused by its specific inhibitor PAI-1
70. Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor
71. 2-macroglobulin receptor-associated protein. Human homologue of a Heymann nephritis antigen
72. A heparin binding protein whose expression increases during differentiation of embryonal carcinoma cells to parietal endoderm cells: cDNA cloning and sequence analysis
73. Molecular cloning of a cDNA encoding a major pathogenic domain of the Heymann nephritis antigen gp330
74. How signal sequences maintian cleavage specificity
75. 2-macroglobulin receptor
76. Binding analysis of amino-terminal and carboxyl-terminal regions of the 39-kDa protein to the low density lipoprotein receptor-related protein
77. Identification of domains on the 39-kDa protein that inhibit the binding of ligands to the low density lipoprotein receptor-related protein
78. Functional domains of the receptor associated protein (RAP)
79. The LDL-receptor related protein, LRP, is an apolipoprotein E binding protein
80. 2-macroglobulin receptor/low density lipoprotein receptorrelated protein binds lipoprotein lipase and p-migrating very low density lipoprotein associated with the lipase
81. The receptorbinding domain of human apolipoprotein E
82. 2-macroglobulin receptor (LRP) and mediates binding of normal very low density lipoproteins to LRP
83. Lipoprotein lipase. Molecular model based on the pancreatic lipase x-ray structure: consequences for heparin binding and catalysis.
84. The receptor-binding domain of human a2macroglobulin: Isolation after limited proteolysis with a bacterial proteinase
85. Domain structure of human a2-macroglobulin: characterization of a receptorbinding domain obtained by digestion with papain
86. Molecular flypaper, host defense, and atherosclerosis
87. gp330 associates with a 44-kDa protein in the rat kidney to for the Heymann nephritis antigenic complex
88. Location of gp330/RAP and is binding sites in kidney: Distribution of endogenous RAP is modified by tissue processing
89. 2-macroglobulin receptor/low density lipoprotein receptorrelated protein and the 39 kD receptor-associated protein in human trophoblasts
90. The 39 kDa receptor associated protein regulates ligand binding by the very low density lipoprotein receptor
91. Invariant chain-a regulator of antigen presentation
92. Association and dissociation of the murine T-cell receptor associated protein (TRAP)
93. Participation of a novel 88-kD protein in the biogenesis of murine class 1 histocompatibility molecules
94. 2- macroglobulin receptor/low density lipoprotein receptor related protein. Differentiation and cAMP modulate protein and mRNA levels
95. 2-macroglobulin receptor (low-density lipoprotein receptorrelated protein) in human brain
96. Apolipoprotein E in sporadic Alzheimer's disease: Allelic variation and receptor interactions
97. 2-macroglobulin receptor/LRP and scavenger receptor in human atherosclerotic lesions
98. Apolipoprotein E: High avidity binding to β-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease
99. A phenocopy of type III dysbetalipoproteinemia occurring in a candidate family for a putative Apo E receptor defect
100. Epithelial glycoprotein-330 mediates endocytosis of plasminogen activator-plasminogen activator inhibitor type-1 complexes